
Overview
As a culminating project for my summer internship in AbbVie’s Pharmacovigilance and Patient Safety department, the intern class was asked to create an innovative digital solution to mitigate risks associated with one of AbbVie’s drugs. My group was assigned Rinvoq, a Janus kinase inhibitor approved for adults with moderate to severe rheumatoid arthritis. We identified potential product safety risks, and decided to focus on the increased risk of blood clots in patient taking Rinvoq. Our solution, the ClotBot, is a digital micro-needle patch that utilizes nanotechnology to detect and destroy blood clots.
Project Details
My Role
Product Design
Time
3 Weeks
Team
4 AbbVie PPS Interns